Eczema Research Study
Researchers at Beth Israel Deaconess Medical Center are evaluating a cream that may improve sleep disturbance caused by itching due to eczema.
Fast Facts
Ages 18+
Diagnosed with Eczema for 2+ Years
Trouble sleeping due eczema-related itch
Compensation Provided
Conducted in Boston, MA
Study Background
BIDMC is studying the response of Opzelura (ruxolitinib 1.5% cream) on sleep disturbance among patients with mild to moderate atopic dermatitis (AD).
This study will determine whether the already FDA-approved cream to treat AD can also reduce sleep disturbance due to itch.
Participants will apply the study cream twice per day on areas of their skin with active atopic dermatitis. Patients will complete daily e-diaries reporting their itch, wear an Oura smart ring, and have a motion-sensing device in their bedroom to track sleep quantity/quality.
Join our compensated study!
Study Background
BIDMC is studying the response of Opzelura (ruxolitinib 1.5% cream) on sleep disturbance among patients with mild to moderate atopic dermatitis (AD).
This study will determine whether the already FDA-approved cream to treat AD can also reduce sleep disturbance due to itch.
Participants will apply the study cream twice per day on areas of their skin with active atopic dermatitis. Patients will complete daily e-diaries reporting their itch, wear an Oura smart ring, and have a motion sensing device in their bedroom to track sleep quantity/quality.
Join our compensated study!
Additional Information
The purpose of this research study is to determine whether Opzelura (ruxolitinib 1.5% cream) improves sleep disturbance in patients with mild-to-moderate atopic dermatitis and itch affecting their sleep.
You may qualify for this study if you meet the following criteria.
Inclusion Criteria:
- Ages 18+
- Diagnosed with eczema for 2 years or more
Active eczema rash affecting > 3% of your body (approximately 3 handprints)
Once enrolled, this study involves:
- Attending 5 in-person study visits
- Completing safety bloodwork, a physical examination, and questionnaires regarding itch and sleep impairment
- Wearing a smart Oura ring to track biometrics
- Using a motion-sensing device in your bedroom to track sleep quantity/quality
- Applying topical medication that is FDA-approved for atopic dermatitis
Participants will be compensated up to $375 for their time and travel compensation is available.
There is no cost for you to participate in our research study.